Matthieu Boucher

2.3k total citations · 1 hit paper
47 papers, 1.8k citations indexed

About

Matthieu Boucher is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Experimental and Cognitive Psychology. According to data from OpenAlex, Matthieu Boucher has authored 47 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pharmacology, 12 papers in Cardiology and Cardiovascular Medicine and 12 papers in Experimental and Cognitive Psychology. Recurrent topics in Matthieu Boucher's work include Treatment of Major Depression (23 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (10 papers) and Mental Health Research Topics (10 papers). Matthieu Boucher is often cited by papers focused on Treatment of Major Depression (23 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (10 papers) and Mental Health Research Topics (10 papers). Matthieu Boucher collaborates with scholars based in United States, Canada and Spain. Matthieu Boucher's co-authors include Walter J. Koch, Erhe Gao, J. Kurt Chuprun, Z. Maggie Huang, Yong Lei, Xiying Shang, Lin Zuo, Qian Fan, Xin L. and Andrea D. Eckhart and has published in prestigious journals such as Circulation, PLoS ONE and Circulation Research.

In The Last Decade

Matthieu Boucher

44 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Novel and Efficient Model of Coronary Artery Ligation and Myocardial Infarction in the Mouse

2010 600 citations Erhe Gao, Yong Lei et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthieu Boucher United States	17	887	705	287	238	172	47	1.8k
Jun Nakamura Japan	29	563 0.6×	237 0.3×	72 0.3×	146 0.6×	144 0.8×	127	1.8k
Kentaro Deguchi Japan	32	914 1.0×	205 0.3×	132 0.5×	170 0.7×	440 2.6×	129	2.8k
Mihail Todiraş Germany	23	728 0.8×	682 1.0×	49 0.2×	197 0.8×	275 1.6×	52	1.9k
Kota Sato Japan	25	567 0.6×	117 0.2×	76 0.3×	133 0.6×	194 1.1×	166	2.0k
Rui Yang China	22	458 0.5×	207 0.3×	73 0.3×	109 0.5×	165 1.0×	92	1.3k
Arto Mannermaa Finland	29	898 1.0×	201 0.3×	136 0.5×	167 0.7×	227 1.3×	74	3.1k
Sandra Barral United States	19	333 0.4×	69 0.1×	158 0.6×	182 0.8×	166 1.0×	43	1.3k
Tomoko Kurata Japan	27	1.2k 1.3×	148 0.2×	102 0.4×	113 0.5×	355 2.1×	87	2.5k
Laurent Monassier France	26	964 1.1×	589 0.8×	148 0.5×	114 0.5×	489 2.8×	85	1.9k

Countries citing papers authored by Matthieu Boucher

Since Specialization

Citations

This map shows the geographic impact of Matthieu Boucher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthieu Boucher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthieu Boucher more than expected).

Fields of papers citing papers by Matthieu Boucher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthieu Boucher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthieu Boucher. The network helps show where Matthieu Boucher may publish in the future.

Co-authorship network of co-authors of Matthieu Boucher

This figure shows the co-authorship network connecting the top 25 collaborators of Matthieu Boucher. A scholar is included among the top collaborators of Matthieu Boucher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthieu Boucher. Matthieu Boucher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Faraone, Stephen V., et al.. (2025). Role of serotonin in psychiatric and somatic comorbidities of attention-deficit/hyperactivity disorder: a systematic literature review. Neuroscience & Biobehavioral Reviews. 176. 106275–106275. 1 indexed citations

Roy, Marc‐André, et al.. (2024). Long-term effectiveness of aripiprazole once monthly on functioning and quality of life in schizophrenia: results of year 2 of the ReLiAM study. BMC Psychiatry. 24(1). 797–797.

Katzman, Martin A., et al.. (2022). Efficacy of adjunctive brexpiprazole on symptom clusters of major depressive disorder: A post hoc analysis of four clinical studies. Journal of Affective Disorders. 316. 201–208. 5 indexed citations

Zilcha‐Mano, Sigal, et al.. (2021). Trajectories of Function and Symptom Change in Desvenlafaxine Clinical Trials. Journal of Clinical Psychopharmacology. 41(5). 579–584.

Kato, Masaki, Yuko Asami, Dalia Wajsbrot, et al.. (2020). Clustering patients by depression symptoms to predict venlafaxine ER antidepressant efficacy: Individual patient data analysis. Journal of Psychiatric Research. 129. 160–167. 6 indexed citations

McIntyre, Roger S., Rita Prieto, Yu‐Chen Yeh, et al.. (2019). Healthcare resource use and cost associated with timing of pharmacological treatment for major depressive disorder in the United States: a real-world study. Current Medical Research and Opinion. 35(12). 2169–2177. 9 indexed citations

Katzman, Martin A., Andrew A. Nierenberg, Dalia Wajsbrot, et al.. (2017). Speed of Improvement in Symptoms of Depression With Desvenlafaxine 50 mg and 100 mg Compared With Placebo in Patients With Major Depressive Disorder. Journal of Clinical Psychopharmacology. 37(5). 555–561. 5 indexed citations

Watanabe, Koichiro, Michael E. Thase, Toshiaki Kikuchi, et al.. (2017). Long-term function and psychosocial outcomes with venlafaxine extended release 75–225 mg/day versus placebo in the PREVENT study. International Clinical Psychopharmacology. 32(5). 271–280. 1 indexed citations

Carrasco, Josep L., Susan G. Kornstein, Roger S. McIntyre, et al.. (2016). An integrated analysis of the efficacy and safety of desvenlafaxine in the treatment of major depressive disorder. International Clinical Psychopharmacology. 31(3). 134–146. 12 indexed citations

10.

Thase, Michael E., Rana Fayyad, Christine J. Guico‐Pabia, et al.. (2015). Effects of desvenlafaxine on blood pressure in patients treated for major depressive disorder: a pooled analysis. Current Medical Research and Opinion. 31(4). 809–820. 7 indexed citations

11.

Messig, Michael, Ching‐Ray Yu, Annlouise R. Assaf, et al.. (2015). The effect of conjugated estrogens/bazedoxifene therapy on body weight of postmenopausal women. Menopause The Journal of The North American Menopause Society. 23(4). 376–382. 9 indexed citations

12.

Kornstein, Susan G., Roger S. McIntyre, Michael E. Thase, & Matthieu Boucher. (2014). Desvenlafaxine for the treatment of major depressive disorder. Expert Opinion on Pharmacotherapy. 15(10). 1449–1463. 13 indexed citations

13.

Lam, Raymond W., Jean Endicott, Ming‐Ann Hsu, et al.. (2014). Predictors of functional improvement in employed adults with major depressive disorder treated with desvenlafaxine. International Clinical Psychopharmacology. 29(5). 239–251. 23 indexed citations

14.

Endicott, Jean, Raymond W. Lam, Ming‐Ann Hsu, et al.. (2014). Improvements in quality of life with desvenlafaxine 50mg/d vs placebo in employed adults with major depressive disorder. Journal of Affective Disorders. 166. 307–314. 13 indexed citations

15.

Fan, Qian, Matthieu Boucher, Xiying Shang, et al.. (2013). Inhibition of Fas-Associated Death Domain-Containing Protein (FADD) Protects against Myocardial Ischemia/Reperfusion Injury in a Heart Failure Mouse Model. PLoS ONE. 8(9). e73537–e73537. 24 indexed citations

16.

Boucher, Matthieu, Stéphanie Pesant, Yong Lei, et al.. (2008). Simultaneous Administration of Insulin‐Like Growth Factor‐1 and Darbepoetin Alfa Protects the Rat Myocardium Against Myocardial Infarction and Enhances Angiogenesis. Clinical and Translational Science. 1(1). 13–20. 23 indexed citations

17.

Pleger, Sven T., Patrick Most, Matthieu Boucher, et al.. (2007). Stable Myocardial-Specific AAV6-S100A1 Gene Therapy Results in Chronic Functional Heart Failure Rescue. Circulation. 115(19). 2506–2515. 139 indexed citations

18.

Bah, Thierno Madjou, Matthieu Boucher, Jérôme Courtemanche, et al.. (2007). Vulnerability for apoptosis in the limbic system after myocardial infarction in rats: a possible model for human postinfarct major depression. Journal of Psychiatry and Neuroscience. 32(1). 11–16. 45 indexed citations

19.

Gao, Erhe, Matthieu Boucher, J. Kurt Chuprun, et al.. (2007). Darbepoetin alfa, a long-acting erythropoietin analog, offers novel and delayed cardioprotection for the ischemic heart. American Journal of Physiology-Heart and Circulatory Physiology. 293(1). H60–H68. 67 indexed citations

20.

Boucher, Matthieu, Stéphanie Pesant, Chantal de Montigny, et al.. (2004). Post-Ischemic Cardioprotection by A2A Adenosine Receptors: Dependent of Phosphatidylinositol 3-Kinase Pathway. Journal of Cardiovascular Pharmacology. 43(3). 416–422. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact